Search
for

    Sort by

    Research 451–480 of 1000+

    1. 1746 INCREASED SERUM C-REACTIVE PROTEIN LEVELS IMPLIES CHRONIC INFLAMMATION IS INVOLVED IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PREDOMINANT STORAGE LOWER URINARY TRACT SYMPTOMS The Journal of Urology · 2013
    2. Efeitos da finasterida sobre culturas de células epiteliais prostáticas normais e tumorais em diferentes sistemas in vitro Americanae (AECID Library) · 2013
    3. Why are men with premature alopecia at higher risk of benign prostatic hyperplasia? And what about prostate cancer? Expert Review of Dermatology · 2012
    4. Squamous metaplasia of the prostate and diffuse alopecia in a 13-year-old castrated dog due to chronic ingestion of exogenous estradiol Open Repository and Bibliography (University of Liège) · 2012
    5. UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia? Urology · 2011
    6. 411 THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER European Urology Supplements · 2011
    7. 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES European Urology Supplements · 2011
    8. Total prostate volume as risk factor for semen pathologies in ageing male Journal of Men's Health · 2010
    9. Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007
    10. Efectos de la terapia combinada del D-004 y el Finasteride sobre la hiperplasia de próstata inducida por testosterona en ratas El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · 2007
    11. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    12. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia? Mayo Clinic Proceedings · 2006
    13. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. The Journal of Urology · 2005
    14. Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer SUNScholar (Stellenbosch University) · 2004
    15. Influencia del tratamiento con alfa bloqueantes e inhibidores de la 5 alfa reductasa en los hallazgos morfológicos e inmunohistoquímicos de la hiperplasia benigna de próstata Dialnet (Universidad de la Rioja) · 2002
    16. Comparación del efecto terapéutico entre el extracto etanólico del fruto de Physalis peruviana, Finasteride y Terazosine en la hiperplasia prostática benigna inducida en ratas Repositorio de Tesis - UNMSM · 2018
    17. Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    18. Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent HAMDAN MEDICAL JOURNAL · 2021
    19. One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital Indian journal of health sciences and biomedical research KLEU · 2017
    20. 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS The Journal of Urology · 2013
    21. Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    22. Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia 2011
    23. 409 ANDROGEN RECEPTOR GENE POLYMORPHISM (SNP RS6152) – ITS RELATIONSHIP TO ANDROGEN-SENSITIVE GENES EXPRESSION IN BENIGN PROSTATIC HYPERPLASIA, CARCINOMA OF THE PROSTATE AND ANDROGENETIC ALOPECIA European Urology Supplements · 2011
    24. 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY The Journal of Urology · 2010
    25. 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia The Year book of endocrinology · 2008
    26. Patients with a large prostate show a higher prevalence of androgenetic alopecia Archives of Dermatological Research · 2005
    27. The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention 2011 · 147 citations
    28. 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice European Urology · 2013 · 7 citations
    29. Alopecia androgenética masculina de inicio precoz asociada a cáncer de próstata 2017
    30. Hair loss at 20 associated with prostate cancer risk later in life Cancer · 2011